Get to know NanoEcho’s chairman Daniel Johnsson
Get to know board professional and NanoEcho’s chairman, Daniel Johnsson – with a strong focus on revolutionising the diagnostics of rectal cancer. Daniel has a background as an engineer, entrepreneur, and investor, along with several assignments in the MedTech and Life Science sectors. With his knowledge and experience, he provides strategic guidance to drive the […]
Watch the live broadcast of the Q3 presentation, hosted by G&W Fondkommission
Watch today’s webcast, where CEO Linda Persson presents NanoEcho’s progress during the third quarter – an eventful period with several significant milestones achieved: Successful issue and listing on the Nasdaq First North Growth Market – An important milestone that contributes to increased visibility and credibility as well as improved liquidity for our shareholders. Doubling the […]
CEO Linda Persson summarises the third quarter
NanoEcho has today published the report for the third quarter! Watch as CEO Linda Persson summarises an eventful quarter, focusing on two key areas: 🏥 During the quarter, the operational team worked intensively to prepare for the dose confirmation study. Shortly after the end of the period, we were proud to announce that all preparations […]
Today the recruitment of study participants in NanoEcho’s clinical study begins!
After extensive preparations, which included, among other things, authority applications, contracting of clinics, assembly and installation of the system as well as training of clinical staff, we can announce that the recruitment of study participants in the dose confirmation study begins today. The dose confirmation study will be conducted at one of CTC’s clinics in […]
What is required to drive growth in life sciences?
What is required to drive growth in life sciences? This was the theme when Linda Persson, CEO of NanoEcho, took to the stage at The Future of Swedish & Danish Life Science 2024 conference in Lund. Linda introduced NanoEcho and shared her experiences from the 10X Health programme, which the company participates in free of […]
Watch the live stream of the Q2 presentation, organised by G&W Fondkommission
During the second quarter, NanoEcho has not only completed product development and passed formal verification but has also successfully certified its quality management system to ISO 13485 and conducted a health economic analysis with promising results. With product development now concluded, NanoEcho is making a clear strategic shift and is now fully focused on the […]
CEO Linda Persson summarises the second quarter of 2024
NanoEcho has today published the report for the second quarter! Watch as CEO Linda Persson summarises the quarter, during which we have not only completed product development and passed the formal verification, but also successfully certified our quality management system according to ISO 13485 and conducted a health economic analysis with promising results. “During this […]
NanoEcho invites to presentation of the Q2 report 2024
On Friday at 2:00 PM, you have the chance to watch as Linda Persson, CEO of NanoEcho, presents the Q2 2024 report. The webcast presentation is organised by G&W Fondkommission. On Friday at 2:00 PM, you have the chance to watch as Linda Persson, CEO of NanoEcho, presents the Q2 2024 report. The webcast presentation […]
Interview with CEO Linda Persson from Dirket Studios
In today’s broadcast from Dirket Studios, NanoEcho’s CEO, Linda Persson, participated. During the interview, Linda discusses the recently completed equity issue, this week’s listing on Nasdaq First North Growth Market, and NanoEcho’s future focus areas. Watch the full interview in Swedish here 👇
Listing on Nasdaq First North Growth Market
August 6 marks a significant milestone for NanoEcho! We are now listed on Nasdaq First North Growth Market. We are incredibly proud of the hard work that has made this possible. A big thank you to all the investors who have continued to trust us, and a warm welcome to all new investors to NanoEcho! […]
